i.osei
TL2 · Osijek
Contributes reviews on supplier material. Based in Osijek.
Joined 10 February 2025 · last posted 6d
76 posts, newest first. Showing up to 150.
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #63 · Clinical › Prescriber conversations · 22 Jul 2026 · 2 likes This is the answer, and the reason it is the answer is the more useful part.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #81 · Compounds › Retatrutide · 21 Jul 2026 · 12 likes Post #78 is the version of this I will quote in future. One addition. Filing a mild objection to the consensus on retatrutide discussion. Mild because I might be wrong;…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #95 · Compounds › Repair & healing peptides · 21 Jul 2026 · 7 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #88 · Practice › Interactions · 18 Jul 2026 · 1 like The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #67 · Practice › Dosing & titration · 15 Jul 2026 · 12 likes Post #66 answers the question as asked. The question underneath it is different. Concentration and dose get conflated constantly in this subcategory. Changing how much…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #24 · Evidence › Preprints · 14 Jul 2026 · 21 likes The claim about community labels upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #121 · Practice › Reconstitution · 12 Jul 2026 · 25 likes Post #119 answers the question as asked. The question underneath it is different. If your arithmetic gives a volume smaller than one graduation on your syringe, the…
-
What steady state means for the decision to escalate Replied, post #24 · Practice › Dosing & titration · 5 Jul 2026 · 0 likes Post #20 describes the usual case. This is about the unusual one. The honest answer on steady state is that it depends, and the useful part is the list of what it…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #2 · Access › Insurance & coverage · 4 Jul 2026 · 0 likes The opening post put the caveat in the right place and I want to underline it. Keep every document with dates in one place. An appeal months later is assembled from…
-
A fridge failure and how I assessed the contents afterwards Replied, post #16 · Devices › Cold chain · 3 Jul 2026 · 13 likes I had written a reply contradicting post #13 and deleted it. Here is what survived. I keep a log for fridge failure specifically because my memory of it turned out to…
-
Journal club: what we got wrong in an earlier session Replied, post #35 · Evidence › Journal club · 28 Jun 2026 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #42 · Clinical › Bloodwork · 9 Jun 2026 · 0 likes A note on scope: what I am saying about Liver enzymes drifting applies to the case in the first post and I would not extend it further without checking.
-
Talking to a therapist about this specifically Replied, post #11 · Wellbeing › Mental health · 9 Jun 2026 · 6 likes I read post #9 twice before replying, because I had assumed the opposite. Social and relationship impacts: weight change affects how others perceive and interact with a…
-
Tracking a shortage from primary sources rather than rumour Replied, post #38 · Access › Shortages · 6 Jun 2026 · 0 likes The most useful contribution is a link to the current official notice rather than an account of one pharmacy.
-
Asking a follow-up: new topic or new reply? Replied, post #2 · Start Here › How to Ask · 5 Jun 2026 · 1 like A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
-
A pooled estimate that changed when one trial was added Replied, post #4 · Evidence › Meta-analyses · 29 May 2026 · 4 likes The forest plot ordered by the variable you think explains the spread is more informative than the pooled diamond, and it is the thing least often reproduced in a…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #81 · Compounds › Tirzepatide · 23 May 2026 · 17 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Prescription requirements and telehealth models — a second dataset Replied, post #37 · Sourcing › Regulatory · 21 May 2026 · 15 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. On balance I think…
-
The headache that turns out to be dehydration — the long version Replied, post #38 · Nutrition & Training › Hydration & electrolytes · 20 May 2026 · 1 like Before the thread moves on from headache — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and…
-
Revisiting: Patterns that reliably precede a problem, documented Replied, post #6 · Sourcing › Red flags · 19 May 2026 · 25 likes Coming back to post #2, because the follow-up matters more than the original answer. If you are new and reading this thread for the answer to Patterns: the answer is…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #22 · Analytics › COA interpretation · 2 May 2026 · 12 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #19 · Analytics › HPLC & UHPLC · 3 Apr 2026 · 5 likes What I want from this Shoulders thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Run-in periods and the population they select Replied, post #90 · Evidence › Trials · 29 Mar 2026 · 1 like On run-in periods, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #81 · Pharmacology › Pharmacokinetics · 24 Mar 2026 · 10 likes Offering a way to settle Washout rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise,…
-
Contributing data without breaching anyone's privacy Replied, post #64 · Data & Tools › Datasets · 6 Mar 2026 · 10 likes Two things can be true about contributing data without breaching at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #136 · Compounds › Semaglutide · 6 Mar 2026 · 11 likes I have three months of notes on semaglutide half-life and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #86 · Access › International · 1 Feb 2026 · 8 likes I had written a reply contradicting post #82 and deleted it. Here is what survived. Both are useful and they are different contributions. A first-hand account and a…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #55 · Meta › Site feedback · 27 Jan 2026 · 27 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #17 · Clinical › Special populations · 21 Jan 2026 · 1 like Narrowing post #16, because the general version has more than one answer. An honest declaration on Pregnancy and pregnancy planning: I have a prior here and it is…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #71 · Compounds › Oral incretins · 9 Dec 2025 · 4 likes The bit of SOUL trial and oral semaglutide that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is…
-
Tracking a preprint to publication: a worked example Replied, post #36 · Evidence › Preprints · 3 Dec 2025 · 26 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
A payment that went through twice: how it was resolved Replied, post #9 · Sourcing › Payments · 21 Nov 2025 · 5 likes Where a supplier issues a quote with an expiry, honouring it after the expiry is a courtesy rather than an entitlement, and several here have found it granted. I keep a…
-
Tracking that stops updating and then resumes — the long version Replied, post #40 · Sourcing › Logistics · 19 Nov 2025 · 10 likes Post #36 and I disagree about the size of the effect, not about the direction. Document outcomes rather than forecasting them. A forecast in this category reads as…
-
Pen dose counters: what a click does and does not guarantee Replied, post #78 · Devices › Pens & autoinjectors · 17 Nov 2025 · 10 likes Picking up post #77: that is the part I would want checked first. Where I would push back on the pen dose counters consensus is the confidence, not the direction. The…
-
Coverage in the US: a map of the usual obstacles Replied, post #10 · Regional › North America · 12 Nov 2025 · 0 likes Appeals succeed more often than people expect when they answer the stated criterion point by point and include nothing else.
-
History of disordered eating and why it changes the conversation Replied, post #21 · Clinical › Special populations · 7 Nov 2025 · 0 likes The useful distinction on history of disordered eating is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them…
-
[2026 update] What steady state means for the decision to escalate Replied, post #13 · Practice › Dosing & titration · 5 Nov 2025 · 9 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #79 · Safety › Adverse events · 1 Nov 2025 · 0 likes Understood. Thank you for being specific about the limits of it.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #105 · Practice › Storage & stability · 27 Oct 2025 · 1 like Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. I have kept the…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #124 · Compounds › Tirzepatide · 24 Oct 2025 · 2 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #7 · Outcomes › Body composition · 20 Oct 2025 · 0 likes Post #3 put the caveat in the right place and I want to underline it. Comparing a body composition result against a population reference is a different exercise from…
-
Second pass at: The mass-error checker and its intended scope Replied, post #40 · Data & Tools › Calculators · 16 Oct 2025 · 0 likes Significant figures in the output should not exceed what the inputs support. A concentration calculated from a nominal vial mass is not known to four decimal places. A…
-
Revisiting: Power cut for eleven hours: how I assessed it afterwards Replied, post #4 · Practice › Storage & stability · 13 Oct 2025 · 0 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Follow-up: Why appetite effects are mostly central Replied, post #62 · Pharmacology › Receptor biology · 9 Oct 2025 · 15 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #111 · Evidence › Study critique · 16 Sep 2025 · 0 likes I would be cautious about generalising from the Reverse causation example above. It is a good example. It is one example.
-
Managing an unplanned gap in supply — what changed since Replied, post #60 · Access › Shortages · 12 Sep 2025 · 0 likes Picking up post #58: that is the part I would want checked first. Answering the Managing an unplanned gap question as asked, then the question I think is meant. As…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #34 · Analytics › Method validation · 6 Sep 2025 · 0 likes The arithmetic in post #31 is right; the assumption feeding it is the part to check. System suitability is the ongoing evidence that a validated method is still…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #115 · Practice › Reconstitution · 29 Aug 2025 · 10 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Travel coolers and how long they really hold Replied, post #15 · Devices › Cold chain · 1 Aug 2025 · 2 likes I changed my mind about travel coolers after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #51 · Evidence › Journal club · 23 Jun 2025 · 0 likes Building on post #48 rather than restating it. An hour is enough for one paper read properly and not enough for two read partly. The temptation is always to add the…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #127 · Compounds › Cagrilintide & amylin analogues · 3 Jun 2025 · 1 like Appreciated. The plain phrasing does more work here than a longer post would.
-
A well-designed study with a badly written abstract Replied, post #67 · Evidence › Study critique · 7 May 2025 · 0 likes Post #66 is the version of this I will quote in future. One addition. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by…
-
Coverage for the indication versus for the drug Replied, post #53 · Access › Insurance & coverage · 4 May 2025 · 19 likes Coverage looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Reading an MS report that only gives you a single number Replied, post #69 · Analytics › Mass spectrometry · 3 May 2025 · 30 likes Narrowing post #68, because the general version has more than one answer. Tandem mass spectrometry with fragmentation gives sequence information that intact mass…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #38 · Outcomes › Progress reports · 11 Apr 2025 · 4 likes Taking post #35 at face value and following it one step further. I keep a log for 18-month record specifically because my memory of it turned out to be systematically…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #53 · Access › Pricing · 3 Apr 2025 · 0 likes Building on post #50 rather than restating it. Cost per milligram is the only comparison that survives format differences, and even then it needs care.
-
Requesting a page: what makes a good request Replied, post #33 · Documentation › Wiki requests · 24 Mar 2025 · 9 likes Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion with specific content you think should be added.
-
Counter-ion content and its effect on measured mass Replied, post #5 · Analytics › Mass spectrometry · 24 Mar 2025 · 2 likes Post #2 is the version of this I will quote in future. One addition. Trifluoroacetate adducts are common in material purified with TFA and are one reason a mass…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #5 · Evidence › Journal club · 1 Mar 2025 · 3 likes Picking up post #2: that is the part I would want checked first. The figures usually contain the finding and the text usually contains the interpretation. Separating…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #32 · Evidence › Meta-analyses · 31 Jan 2025 · 32 likes Building on post #29 rather than restating it. On Random versus fixed effects, the part that usually goes wrong is that the question is asked as though it has one…
-
UK access routes, dated and sourced — a second dataset Replied, post #31 · Regional › UK & Ireland · 26 Jan 2025 · 4 likes On post #27 — agreed on the reasoning, with one qualification. Where guidance distinguishes between indications, quoting the indication is essential. The same compound…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #43 · Compounds › Oral incretins · 12 Jan 2025 · 6 likes Missed doses behave differently for a daily oral than for a weekly injection. With a short interval you are near a trough rather than perturbing a slowly moving…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #16 · Pharmacology › Receptor biology · 1 Jan 2025 · 1 like Answering the question post #15 raises rather than the one it answers. Cross-reactivity at related receptors within the secretin family is real and is one reason…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #92 · Compounds › Semaglutide · 24 Dec 2024 · 25 likes On the "does it stop working" question: tolerance in the pharmacological sense is not what the withdrawal trials show. What they show is that the effect persists while…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #11 · Practice › Reconstitution · 14 Dec 2024 · 6 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #18 · Data & Tools › Calculators · 13 Dec 2024 · 0 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
Individual participant data versus aggregate data Replied, post #9 · Evidence › Meta-analyses · 28 Nov 2024 · 1 like Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. That is all I can say…
-
Washout with a one-week half-life: the arithmetic Replied, post #27 · Research Methods › N-of-1 designs · 27 Nov 2024 · 18 likes A washout period between conditions is what stops one bleeding into the next, and its length should be set by the half-life rather than by convenience. It reads as…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #41 · Compounds › Tirzepatide · 17 Nov 2024 · 25 likes Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks rather than four. That is a real difference from semaglutide and it…
-
Blind submission and why it changes minds Replied, post #95 · Sourcing › Independent verification · 22 Oct 2024 · 4 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. It is one…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #3 · Compounds › Retatrutide · 24 Aug 2024 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Why I ask for the gradient before I discuss the number Replied, post #15 · Analytics › HPLC & UHPLC · 23 Aug 2024 · 9 likes Building on post #12 rather than restating it. A shoulder on the trailing edge is most often a closely related species rather than an artefact. The way to find out is…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #30 · Clinical › Prescriber conversations · 1 Aug 2024 · 25 likes Nothing here is medical advice, and this subcategory exists to help people ask better questions rather than to answer them. Written from notes rather than memory, which…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #86 · Compounds › Retatrutide · 22 Jul 2024 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #11 · Practice › Dosing & titration · 6 Jul 2024 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
The mass-error checker and its intended scope Replied, post #93 · Data & Tools › Calculators · 3 Jul 2024 · 15 likes I would rather this thread reach "we do not know" about mass-error checker than reach a confident answer that nobody can support when asked.